Adverse drug reactions
- PMID: 27697815
- PMCID: PMC6297296
- DOI: 10.7861/clinmedicine.16-5-481
Adverse drug reactions
Abstract
Adverse drug reactions (ADRs) remain a challenge in modern healthcare, particularly given the increasing complexity of therapeutics, an ageing population and rising multimorbidity. This article summarises some of the key facts about ADRs and explores aspects relating to their prevention, diagnosis, reporting and management in current clinical practice.
Keywords: Adverse drug reactions; adverse drug reaction reporting systems; clinical pharmacology; drug-related side effects and adverse reactions; pharmacovigilance.
© Royal College of Physicians 2016. All rights reserved.
References
-
- Aronson JK. Ferner RE. Clarification of terminology in drug safety. Drug Saf. 2005;28:851–70. - PubMed
-
- European Directive 2010/84/EU of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use
-
- Bates DW. Leape LL. Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med. 1993;8:289–94. - PubMed
-
- Lazarou J. Pomeranz BH. Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical